-
-
-
-
-
-
-
Fulgent Genetics, Inc. Investigated by the Portnoy Law Firm
-
-
-
-
-
-
-
Fulgent Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Fulgent Genetics, Inc. (FLGT) Tops Q1 EPS by 12c ; Offers Guidance
-
-
-
-
-
-
-
Fulgent Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Fulgent Genetics, Inc. (FLGT) Tops Q1 EPS by 31c ; Offers Guidance
-
-
-
-
-
-
-
Fulgent Genetics, Inc. (FLGT) Misses Q3 EPS by 7c ; Offers Guidance
-
-
-
-
-
-
-
Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers
-
1,214,511 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

